Effect and Safety of dose-escalating treatment of Imidafenacin for Overactive Bladder : CLSS-modified-Self-Assessment Goal Achievement questionnaire

Trial Profile

Effect and Safety of dose-escalating treatment of Imidafenacin for Overactive Bladder : CLSS-modified-Self-Assessment Goal Achievement questionnaire

Completed
Phase of Trial: Phase III

Latest Information Update: 13 May 2016

At a glance

  • Drugs Imidafenacin (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Acronyms CLSS-modified-SAGA
  • Most Recent Events

    • 27 Jan 2014 Status changed from active, no longer recruiting to completed as reported by the University Hospital Medical Information Network, Japan record.
    • 23 Jan 2013 Planned End Date changed from 1 Mar 2012 to 31 Mar 2013 as reported by University Hospital Medical Information Network - Japan.
    • 23 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top